Literature DB >> 11007004

Emergence of subtype strains of the Arkansas serotype of infectious bronchitis virus in Delmarva broiler chickens.

W A Nix1, D S Troeber, B F Kingham, C L Keeler, J Gelb.   

Abstract

Infectious bronchitis virus (IBV) field isolates of the Arkansas (Ark) serotype were identified by reverse transcription-polymerase chain reaction (RT-PCR) as the most common serotype isolated from 1993 to 1997. These isolates were recovered from broiler flocks with respiratory disease raised on the Delmarva peninsula in spite of Ark vaccination in the region. For the purposes of investigating this apparently paradoxical finding, five RT-PCR Ark-positive field isolates recovered in 1995 and 1996 were selected for further characterization. The isolates were compared with Ark reference strains by reciprocal virus neutralization (VN) in embryonated eggs, S-1 gene sequence analysis, and challenge of immunity studies in specific-pathogen-free (SPF) chickens. Antigenic (VN) comparisons and S-1 gene analysis confirmed that the five RT-PCR Ark-positive field isolates were of the Ark serotype but also revealed that the viruses could be readily distinguished from Ark reference strains. Four of the isolates (Ark/213/96, Ark/15C/96, Ark/1529/95, Ark/1534/95) were found to have higher antigenic relatedness percentages to each other (95%-100%) than to Ark reference strains DPI (52%-72%) and Georgia variant (Georgia var) (53%-68%) by VN. Another isolate, Ark/1535/95, was found to differ antigenically from the other four RT-PCR Ark-positive field isolates (34%-61%), Ark DPI (44%), and Georgia var (43%) strains. The trends in the S-1 gene sequencing results were similar to those observed for the VN findings. Isolates Ark/213/96, Ark/15C/96, Ark/1529/95, and Ark/1534/95 demonstrated a higher degree of predicted S-1 amino acid similarity to each other (96.5%-98.7%) than to Ark DPI (92.4%-93.7%), Ark 99 (93.2%-94.7%), and Georgia var (89.3%-90.8%). Ark/1535/95 S-1 amino acid similarity values were lower compared with those of the other four RT-PCR Ark-positive field isolates (93.4%-94.8%), Ark DPI (91.9%), Ark 99 (93.0%), and Georgia var (88.7%). Furthermore, the isolates could be distinguished from the Ark reference strains by a characteristic sequence polymorphism, a six-nucleotide deletion encoding amino acids 57 (Asp) and 58 (Asp) in hypervariable region 1 of S-1. On the basis of the VN and sequencing findings, isolates Ark/213/96, Ark/15C/96, Ark/1529/95, and Ark/1534/95 were considered to be a single subtype of the Ark serotype. The fifth isolate, Ark/1535/95, may constitute another subtype of the Ark serotype. Vaccination of SPF chickens with a high-titering commercially available live vaccine containing the Ark DPI strain provided solid protection (>90%) against challenge with the RT-PCR Ark-positive field isolates. Immunization of SPF chickens with Ark/213/96 produced 100% protection against challenge with the homologous strain, as well as isolates Ark/1535/95 and Ark 99 but lower levels of protection against Ark DPI (58%) and Georgia var (55%). Primers for RT-PCR were designed to distinguish between the Ark subtypes and the Ark reference strains on the basis of the characteristic six-nucleotide deletion identified in the S-1 gene of the Ark subtypes. Retrospective analysis of RT-PCR Ark-positive isolates found that the Ark subtypes existed as early as 1992 in Delmarva broilers and became prevalent by 1995. With RT-PCR, restriction fragment length polymorphism analysis, and DNA sequencing techniques, the presence of Ark subtype viruses was demonstrated in two commercial Ark DPI strain vaccines and in our Ark DPI laboratory stocks that were the original source of the virus used for vaccine development. The demonstration of the Ark subtype and reference strains in the Ark DPI strain is evidence of the existence of IBV quasispecies. Factors possibly influencing the emergence of the Ark subtype in commercial broilers are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11007004

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  18 in total

1.  Recombinant infectious bronchitis coronavirus Beaudette with the spike protein gene of the pathogenic M41 strain remains attenuated but induces protective immunity.

Authors:  Teri Hodgson; Rosa Casais; Brian Dove; Paul Britton; Dave Cavanagh
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Pathogenicity of infectious bronchitis virus isolates from Ontario chickens.

Authors:  Helena Grgić; D Bruce Hunter; Peter Hunton; Eva Nagy
Journal:  Can J Vet Res       Date:  2008-10       Impact factor: 1.310

Review 3.  Progress and challenges toward the development of vaccines against avian infectious bronchitis.

Authors:  Faruku Bande; Siti Suri Arshad; Mohd Hair Bejo; Hassan Moeini; Abdul Rahman Omar
Journal:  J Immunol Res       Date:  2015-04-14       Impact factor: 4.818

4.  A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV.

Authors:  Edris Shirvani; Anandan Paldurai; Vinoth K Manoharan; Berin P Varghese; Siba K Samal
Journal:  Sci Rep       Date:  2018-08-10       Impact factor: 4.379

5.  Attenuated live vaccine usage affects accurate measures of virus diversity and mutation rates in avian coronavirus infectious bronchitis virus.

Authors:  Enid T McKinley; Mark W Jackwood; Deborah A Hilt; Jessica C Kissinger; Jon S Robertson; Cornelia Lemke; Andrew H Paterson
Journal:  Virus Res       Date:  2011-04-22       Impact factor: 3.303

6.  Characterization and analysis of an infectious bronchitis virus strain isolated from southern China in 2013.

Authors:  Gang Xu; Xiao-Yu Liu; Ye Zhao; Yang Chen; Jing Zhao; Guo-Zhong Zhang
Journal:  Virol J       Date:  2016-03-09       Impact factor: 4.099

7.  Genetic diversity of avian infectious bronchitis coronavirus strains isolated in China between 1995 and 2004.

Authors:  S W Liu; Q X Zhang; J D Chen; Z X Han; X Liu; L Feng; Y H Shao; J G Rong; X G Kong; G Z Tong
Journal:  Arch Virol       Date:  2006-01-09       Impact factor: 2.574

8.  Polymorphisms in the S1 spike glycoprotein of Arkansas-type infectious bronchitis virus (IBV) show differential binding to host tissues and altered antigenicity.

Authors:  Christina Leyson; Monique França; Mark Jackwood; Brian Jordan
Journal:  Virology       Date:  2016-09-15       Impact factor: 3.616

9.  Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination.

Authors:  Enid T McKinley; Deborah A Hilt; Mark W Jackwood
Journal:  Vaccine       Date:  2008-01-18       Impact factor: 3.641

Review 10.  Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.

Authors:  Dave Cavanagh
Journal:  Avian Pathol       Date:  2003-12       Impact factor: 3.378

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.